Once-weekly compared with three-times-weekly subcutaneous epoetin β: Results from a randomized, multicenter, therapeutic-equivalence study

This publication has 17 references indexed in Scilit:

• The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trial
  Nephrology Dialysis Transplantation, 2000
• Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
  Kidney International, 2000
• Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis
  New England Journal of Medicine, 1998
• The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry
  Nephrology Dialysis Transplantation, 1998
• The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
  Published by Elsevier ,1996
• Efficiency of Once-Weekly Subcutaneous Administration of Recombinant Human Erythropoietin versus Three Times a Week Administration in Hemodialysis Patients
  Nephron, 1996
• Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP working party on efficacy of medicinal products note for guidance III/3630/92‐EN
  Statistics in Medicine, 1995
• Once Weekly versus Twice Weekly Subcutaneous Administration of Recombinant Human Erythropoietin in Haemodialysis Patients
  American Journal of Nephrology, 1992
• Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
  Annals of Internal Medicine, 1989
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
  Journal of Pharmacokinetics and Biopharmaceutics, 1987